Finally, a meta-analysis performed by Caldeira et al. in 2012 looked at 37 studies demonstrating that ACE inhibitors were associated with a significantly reduced risk of pneumonia in comparison to control treatment and ARBs [186]. Here, ACE is linked to pneumonia.